Aptinyx, Allergan deal

Newco Aptinyx and Allergan will collaborate on the discovery and preclinical development of oral small molecule NMDA receptor modulators to treat psychiatric and neurologic disorders. Allergan has the right to in-license an undisclosed number of candidates. The companies declined to disclose details and financial terms. ...